TY - JOUR
T1 - Updating the approach to Crohn's disease
AU - Hanauer, Stephen B.
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 1999/8/15
Y1 - 1999/8/15
N2 - Recognizing clinical and pathologic scenarios, rather than ordering definitive tests, is still the basis for diagnosis of Crohn's disease. Steroids, salicylates, immunomodulating agents, and surgery remain the focus of treatment. The advent of infliximab, however, offers a new therapeutic option for patients with refractory disease.
AB - Recognizing clinical and pathologic scenarios, rather than ordering definitive tests, is still the basis for diagnosis of Crohn's disease. Steroids, salicylates, immunomodulating agents, and surgery remain the focus of treatment. The advent of infliximab, however, offers a new therapeutic option for patients with refractory disease.
UR - http://www.scopus.com/inward/record.url?scp=0033567206&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033567206&partnerID=8YFLogxK
U2 - 10.1080/21548331.1999.11443892
DO - 10.1080/21548331.1999.11443892
M3 - Article
C2 - 10459364
AN - SCOPUS:0033567206
VL - 34
SP - 77
EP - 94
JO - Hospital practice (1995)
JF - Hospital practice (1995)
SN - 2154-8331
IS - 8
ER -